Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer

Lignende værker

• A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
  af: Ma, Xinrong, et al.
  Udgivet: (2013)
• Prostaglandin E(2) (PGE(2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4
  af: Holt, Dawn, et al.
  Udgivet: (2011)
• Upregulation of Cyclooxygenase-2/Prostaglandin E(2) (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
  af: Kochel, Tyler J., et al.
  Udgivet: (2016)
• Divergent Roles of CXCR3 Isoforms in Promoting Cancer Stem Cell Survival and Metastasis
  af: Li, Yanchun, et al.
  Udgivet: (2014)
• Multiple Drug Resistance-Associated Protein 4 (MRP4), Prostaglandin Transporter (PGT), and 15-Hydroxyprostaglandin Dehydrogenase (15-PGDH) as Determinants of PGE(2) Levels in Cancer
  af: Kochel, Tyler J., et al.
  Udgivet: (2014)